Does inflammation markers or treatment type moderate exercise intensity effects on changes in muscle strength in cancer survivors participating in a 6-month combined resistance- and endurance exercise program? Results from the Phys-Can trial

Does inflammation markers or treatment type moderate exercise intensity effects on changes in muscle strength in cancer survivors participating in a 6-month combined resistance- and endurance exercise program? Results from the Phys-Can trial

Abstract Background Resistance exercise has a beneficial impact on physical function for patients receiving oncological treatment. However, there is an inter-individual variation in the response to exercise and the tolerability to high-intensity exercise. Identifying potential moderating factors, su...

Full description

Bibliographic Details
Main Authors: Anna Henriksson, Emelie Strandberg, Andreas Stenling, Anne-Sophie Mazzoni, Katarina Sjövall, Sussanne Börjeson, Truls Raastad, Ingrid Demmelmaier, Sveinung Berntsen, Karin Nordin
Format: Article
Language:English
Published: BMC 2023-01-01
Series:BMC Sports Science, Medicine and Rehabilitation
Subjects:
Androgen deprivation therapy
Cancer
Chemotherapy
Exercise intensity
Moderators
Inflammation
Online Access:https://doi.org/10.1186/s13102-023-00617-3

Internet

https://doi.org/10.1186/s13102-023-00617-3

Similar Items